Labita, Frandle Flynnt Hartlie L.

HRN: 26-52-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2025
CEFUROXIME 750MG (VIAL)
07/24/2025
07/30/2025
IV
210mg
Q8h
Acute Bacterial Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: